Association of ESAs and Cancer Risk Among Dialysis Patients Association of ESAs and Cancer Risk Among Dialysis Patients
Erythropoiesis-stimulating agents are commonly used to treat anemia in ESRD patients, but they may be linked to a higher incidence of cancer.Nephrology Dialysis Transplantation
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
More News: Anemia | Cancer | Cancer & Oncology | Dialysis | Health | Transplants | Urology & Nephrology